Wegovy (Semaglutide) Injection
$150.00Why Choose Wegovy?
Wegovy is FDA-approved and offers a once-weekly injection regimen, proven to assist in significant weight loss when combined with lifestyle changes.
How to Use
Administer once weekly on the same day each week, at any time of day, with or without meals. Use a new needle for each injection. Follow your healthcare provider's dosage titration schedule.
Safety Information
Do not use if you or your family have a history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Risk of hypoglycemia with insulin/sulfonylurea. Risk of pancreatitis.
Potential Side Effects
Common side effects include nausea, diarrhea, vomiting, constipation, and stomach pain, which often decrease over time.
Product Facts
| Generic Name | Semaglutide |
| Brand Name | Wegovy |
| Type of Medication | Glucagon-like peptide-1 (GLP-1) receptor agonist |
| FDA Approval Date | June 4, 2021 |
| Indications | Chronic weight management. |
| Dosage Forms | Subcutaneous injection (pre-filled pen) |
| Administration | Once weekly |
| Special Precautions | Monitor for symptoms of pancreatitis and gallbladder disease. May cause renal impairment or diabetic retinopathy complications. |
| Drug Interactions | Slows gastric emptying; may affect absorption of oral medications. |
| Use in Specific Populations | Caution in elderly, not studied in pediatric patients with type 2 diabetes. Avoid during pregnancy. |
| Prescription | Prescription required |
| Manufacturer | Novo Nordisk |
How to Buy
This is a prescription medication. Consultation and prescription required. Order online and pick up at a certified pharmacy.